Literature DB >> 2170684

Unique amino acid substitutions in the capsid proteins of foot-and-mouth disease virus from a persistent infection in cell culture.

J Díez1, M Dávila, C Escarmís, M G Mateu, J Dominguez, J J Pérez, E Giralt, J A Melero, E Domingo.   

Abstract

Maintenance of a persistent foot-and-mouth disease virus (FMDV) infection in BHK-21 cells involves a coevolution of cells and virus (J. C. de la Torre, E. Martínez-Salas, J. Díez, A. Villaverde, F. Gebauer, E. Rocha, M. Dávila, and E. Domingo, J. Virol. 62:2050-2058, 1988). The resident FMDV undergoes a number of phenotypic changes, including a gradual decrease in virion stability. Here we report the nucleotide sequence of the P1 genomic segment of the virus rescued after 100 passages of the carrier cells (R100). Only 5 of 15 mutations in P1 of R100 were silent. Nine amino acid substitutions were fixed on the viral capsid during persistence, and three of the variant amino acids are not represented in the corresponding position of any picornavirus sequenced to date. Cysteine at position 7 of VP3, that provides disulfide bridges at the FMDV fivefold axis, was substituted by valine, as determined by RNA, cDNA, and protein sequencing. The modified virus shows high buoyant density in cesium chloride and depicts the same sensitivity to photoinactivation by intercalating dyes as the parental FMDV C-S8c1. Amino acid substitutions fixed in VP1 resulted in altered antigenicity, as revealed by reactivity with monoclonal antibodies. In addition to defining at the molecular level the alterations the FMDV capsid underwent during persistence, the results show that positions which are highly invariant in an RNA genome may change when viral replication occurs in a modified environment.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2170684      PMCID: PMC248604          DOI: 10.1128/JVI.64.11.5519-5528.1990

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  50 in total

Review 1.  RNA virus evolution and the control of viral disease.

Authors:  E Domingo
Journal:  Prog Drug Res       Date:  1989

2.  The three-dimensional structure of foot-and-mouth disease virus at 2.9 A resolution.

Authors:  R Acharya; E Fry; D Stuart; G Fox; D Rowlands; F Brown
Journal:  Nature       Date:  1989-02-23       Impact factor: 49.962

3.  Implications of a quasispecies genome structure: effect of frequent, naturally occurring amino acid substitutions on the antigenicity of foot-and-mouth disease virus.

Authors:  M G Mateu; M A Martínez; E Rocha; D Andreu; J Parejo; E Giralt; F Sobrino; E Domingo
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

4.  Extensive antigenic heterogeneity of foot-and-mouth disease virus of serotype C.

Authors:  M G Mateu; J L Da Silva; E Rocha; D L De Brum; A Alonso; L Enjuanes; E Domingo; H Barahona
Journal:  Virology       Date:  1988-11       Impact factor: 3.616

5.  3D gene of foot-and-mouth disease virus. Conservation by convergence of average sequences.

Authors:  A Villaverde; E Martínez-Salas; E Domingo
Journal:  J Mol Biol       Date:  1988-12-05       Impact factor: 5.469

6.  Molecular cloning of cDNA from foot-and-mouth disease virus C1-Santa Pau (C-S8). Sequence of protein-VP1-coding segment.

Authors:  N Villanueva; M Dávila; J Ortín; E Domingo
Journal:  Gene       Date:  1983-08       Impact factor: 3.688

7.  A single amino acid substitution affects multiple overlapping epitopes in the major antigenic site of foot-and-mouth disease virus of serotype C.

Authors:  M G Mateu; M A Martínez; L Capucci; D Andreu; E Giralt; F Sobrino; E Brocchi; E Domingo
Journal:  J Gen Virol       Date:  1990-03       Impact factor: 3.891

8.  Resistance to foot-and-mouth disease virus mediated by trans-acting cellular products.

Authors:  J C de la Torre; S de la Luna; J Diez; E Domingo
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

9.  Antigenic variation of foot-and-mouth disease virus of serotype C during propagation in the field is mainly restricted to only one structural protein (VP1).

Authors:  F Sobrino; M A Martinez; C Carrillo; E Beck
Journal:  Virus Res       Date:  1989-12       Impact factor: 3.303

10.  Selection of antigenic variants of foot-and-mouth disease virus in the absence of antibodies, as revealed by an in situ assay.

Authors:  J Diez; M G Mateu; E Domingo
Journal:  J Gen Virol       Date:  1989-12       Impact factor: 3.891

View more
  34 in total

1.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1991-06-11       Impact factor: 16.971

2.  Episodic evolution mediates interspecies transfer of a murine coronavirus.

Authors:  R S Baric; B Yount; L Hensley; S A Peel; W Chen
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

3.  Effects of macromolecular crowding on the inhibition of virus assembly and virus-cell receptor recognition.

Authors:  Verónica Rincón; Rebeca Bocanegra; Alicia Rodríguez-Huete; Germán Rivas; Mauricio G Mateu
Journal:  Biophys J       Date:  2011-02-02       Impact factor: 4.033

4.  Virulence as a positive trait in viral persistence.

Authors:  J C Sáiz; E Domingo
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

5.  VP1-coding sequences of recent isolates of foot-and-mouth disease virus types A, O and Asia1.

Authors:  O Marquardt; B Haas
Journal:  Virus Genes       Date:  1998       Impact factor: 2.332

6.  HSV type 1 genome variants from persistently productive infections in Raji and BJAB cell lines.

Authors:  S M Klauck; W Hampl; A K Kleinschmidt
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

7.  Ultrastructural and replicative features of foot-and-mouth disease virus in persistently infected BHK-21 cells.

Authors:  A Donn; M Castagnaro; A I Donaldson
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

8.  Antigenic heterogeneity of a foot-and-mouth disease virus serotype in the field is mediated by very limited sequence variation at several antigenic sites.

Authors:  M G Mateu; J Hernández; M A Martínez; D Feigelstock; S Lea; J J Pérez; E Giralt; D Stuart; E L Palma; E Domingo
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

9.  Engineering viable foot-and-mouth disease viruses with increased thermostability as a step in the development of improved vaccines.

Authors:  Roberto Mateo; Eva Luna; Verónica Rincón; Mauricio G Mateu
Journal:  J Virol       Date:  2008-10-01       Impact factor: 5.103

10.  Initial fitness recovery of HIV-1 is associated with quasispecies heterogeneity and can occur without modifications in the consensus sequence.

Authors:  Antonio V Bordería; Ramon Lorenzo-Redondo; Maria Pernas; Concepción Casado; Tamara Alvaro; Esteban Domingo; Cecilio Lopez-Galindez
Journal:  PLoS One       Date:  2010-04-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.